US-based medical technology provider Boston Scientific has commenced a clinical trial to evaluate whether occipital nerve stimulation (ONS) using the Precision System can safely and effectively treat chronic migraine when used in conjunction with anti-migraine medications.
Boston Scientific Precision System features multiple independent current control (MICC) technology.
Through ONS, a small programmable implanted device sends electrical impulses to the greater occipital nerve, which runs from the top of the spinal cord to the base of the scalp.
Earlier studies suggested that by stimulating the occipital nerve, there could be a possibility to reduce the pain associated with chronic migraine.
According to World Health Organization (WHO), migraine is considered to be one of the top disabling conditions worldwide.
Boston Scientific Neuromodulation president Maulik Nanavaty said, "We believe that the Boston Scientific neurostimulation therapy for migraine has enormous potential to help migraine sufferers worldwide."
